Microvascular complications in prediabetes: a systematic review & meta-analysis

Sama Thiab1, Taim Akhal1, Meriem Akeblersane1

  • 1School of Medicine, Royal College of Surgeons in Ireland Bahrain, Busaiteen 15503, Bahrain.

Insights

The American Diabetes Association (ADA) prediabetes criteria (HbA1c ≥ 5.7%) identify more retinopathy than International Experts Committee (IEC) criteria. ADA criteria are preferable for early retinopathy detection in prediabetes.

Area of Science:

  • Endocrinology
  • Ophthalmology
  • Nephrology

Background:

  • Rising prediabetes prevalence increases microvascular complication risk.
  • Discrepancies exist between ADA (HbA1c 5.7-6.4%) and IEC (HbA1c 6.0-6.4%) prediabetes definitions.
  • Identifying optimal prediabetes screening criteria for microvascular complications is crucial.

Purpose of the Study:

  • To determine if a specific prediabetes hemoglobin A1c (HbA1c) or fasting blood glucose (FBG) threshold increases microvascular complications.
  • To compare the efficacy of ADA versus IEC criteria in identifying retinopathy risk.

Main Methods:

  • Systematic review of prediabetes studies (1990-May 2023) in major databases.
  • Included studies reporting retinopathy, nephropathy, and/or neuropathy.
  • Analyzed 35 studies out of 21,215 identified.

Main Results:

  • ADA criteria identified significantly higher prevalence and incidence of retinopathy compared to IEC criteria.
  • Receiver Operator Curve analysis showed better performance for IEC criteria in retinopathy detection (AUC 0.88) versus ADA criteria (AUC 0.73).
  • Limited data available for nephropathy and neuropathy prevalence in prediabetes.

Conclusions:

  • ADA prediabetes criteria (HbA1c 5.7-6.4%) are more sensitive for detecting retinopathy than IEC criteria (HbA1c 6.0-6.4%).
  • Clinical retinal screening may be beneficial for individuals with HbA1c ≥ 5.7%.
  • Further research is needed on nephropathy and neuropathy prevalence in prediabetes.
Abstract

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
515
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
894